About the Company
optimizerx partners with pharmaceutical companies to offer electronic versions of their patient savings and support materials within the eprescribing workflow of leading electronic health record platforms. using the samplemd technology, providers can more efficiently distribute savings and support materials to their patients. the ecoupon technology, available in the eprescribing workflow of over 300,000+ providers, has expanded the distribution of savings and support materials to millions of patients throughout the us and aims to increase adherence rates and affordability of prescribed medications. about optimizerx corp. optimizerx corp. provides unique consumer and physician platforms to help patients better afford and comply with their medications, while offering pharmaceutical companies effective ways to expand awareness, affordability and adherence to their brands. for more information on samplemd, please call us at (877) 568-3840 or visit www.samplemd.com.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $OPRX News
Q4 2023 OPTIMIZERx Corp Earnings Call
Stephanie Davis; Analyst; Barclays William Wood; Analyst; B. Riley Securities ...
OptimizeRx (NASDAQ: OPRX)
OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to ...
OptimizeRx: Exponential Growth Drives The Valuation Cheaper
OptimizeRx is a provider of AI-based software solutions for healthcare distributors and physicians. Click here to read an ...
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
WALTHAM, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies ...
OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort
WALTHAM, Mass., March 04, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach ...
OptimizeRx maintains revenue outlook amid reporting update
WALTHAM, Mass. - OptimizeRx Corp. (NASDAQ:OPRX), a prominent healthcare technology solutions provider, has reaffirmed its revenue and adjusted EBITDA estimates for the fiscal year 2023.
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
WALTHAM, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences ...
Loading the latest forecasts...